Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Unsaturated fatty acids [FA0103]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA01031012 hexa-2,4-dienoic acid hexa-2,4-dienoic acid FA 6:2 C6H8O2 112.052430
LMFA01031013 Lumequic acid (21E)-triacont-21-enoic acid FA 30:1 C30H58O2 450.443681
LMFA01031015 mediomycin A (2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid C62H97NO18S 1175.642641
LMFA01031016 mediomycin B (2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,29,33,35,39,41,43,47,49,53,55-dodecahydroxy-2,12,14,30-tetramethyl-31-oxooctapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid C62H97NO15 1095.685825
LMFA01031018 penta-2,4-dienoic acid penta-2,4-dienoic acid FA 5:2 C5H6O2 98.036780
LMFA01031021 trans-2-hexacosenoic acid (2E)-hexacos-2-enoic acid FA 26:1 C26H50O2 394.381081
LMFA08020162 (E,E)-2,4-Decadienoic isobutylamide (2E,4Z)-N-(2-methylpropyl)deca-2,4-dienamide NA 14:2 C14H25NO 223.193614
LMFA08020164 2,4-Undecadiene-8,10-diynoic acid isobutylamide (2E,4Z)-N-(2-methylpropyl)undeca-2,4-dien-8,10-diynamide NA 15:6 C15H19NO 229.146664
LMFA08020165 Anacyclin (2E,4E)-N-isobutyltetradeca-2,4-dien-8,10-diynamide NA 18:6 C18H25NO 271.193614
LMFA08020166 asukamycin (2E,4E,6E)-7-cyclohexyl-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]hepta-2,4,6-trienamide C31H34N2O7 546.236603
LMFA08020167 beta-sanshool (2E,6E,8E,10E)-N-(2-methylpropyl)dodeca-2,6,8,10-tetraenamide NA 16:4 C16H25NO 247.193614
LMFA08020168 BRN 2646116 (2E,4E)-N-isobutyl-6-phenyl-hexa-2,4-dienamide NA 16:6 C16H21NO 243.162314
LMFA08020172 EI-1511-3 (2E,4E)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-7-methylocta-2,4-dienamide C27H30N2O7 494.205303
LMFA08020173 EI-1511-5 (2E,4E,6E)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-8-methyldeca-2,4,6-trienamide C29H32N2O7 520.220953
LMFA08020174 EI-1625-2 (2E)-N-[(1S,5R,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-4-methyloct-2-enamide C27H32N2O7 496.220953
LMFA08020176 FR901463 6-[(1E,3E)-5-(5-{[(2Z)-4-(acetyloxy)pent-2-enoyl]amino}-3,6-dimethyltetrahydro-2H-pyran-2-yl)-3-methylpenta-1,3-dien-1-yl]-4-C-(chloromethyl)-1,3-dideoxy-alpha-D-erythro-hex-2-ulopyranose C27H42NO8Cl 543.259897
LMFA08020177 FR901464 (2S,3Z)-5-{[(2R,3R,5S,6S)-6-{(2E,4E)-5-[(3R,4R,5R,7S)-4,7-dihydroxy-7-methyl-1,6-dioxaspiro[2.5]oct-5-yl]-3-methylpenta-2,4-dien-1-yl}-2,5-dimethyltetrahydro-2H-pyran-3-yl]amino}-5-oxopent-3-en-2-yl acetate NA 27:7;O7 C27H41NO8 507.283219
LMFA08020178 FR901465 (2S,3Z)-5-{[(2R,3R,5S,6S)-2,5-dimethyl-6-{(2E,4E)-3-methyl-5-[(3R,4R,5R,7S,8R)-4,7,8-trihydroxy-7-methyl-1,6-dioxaspiro[2.5]oct-5-yl]penta-2,4-dien-1-yl}tetrahydro-2H-pyran-3-yl]amino}-5-oxopent-3-en-2-yl acetate NA 27:7;O8 C27H41NO9 523.278134
LMFA08020179 gamma-sanshool N-(2-methylpropyl)tetradeca-2E,4E,8Z,10E,12E-pentaenamide NA 18:5 C18H27NO 273.209264
LMFA08020180 Herculin (2E,8E)-N-(2-methylpropyl)dodeca-2,8-dienamide NA 16:2 C16H29NO 251.224914
LMFA08020181 Hydroxy-epsilon-sanshool (2E,6Z,8E,10Z)-N-(2-hydroxy-2-methylpropyl)dodeca-2,6,8,10-tetraenamide NA 16:4;O C16H25NO2 263.188529
LMFA08020185 manumycin (2E,4E,6R)-N-[(1S,5S,6R)-5-hydroxy-5-[(1E,3E,5E)-7-[(2-hydroxy-5-oxo-cyclopenten-1-yl)amino]-7-oxo-hepta-1,3,5-trienyl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-trimethyl-deca-2,4-dienamide C31H38N2O7 550.267903
LMFA08020186 N-(2-Hydroxyisobutyl)-2,4,8,10,12-tetradecapentaenamide (2E,4E,8E,10E,12E)-N-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide NA 18:5;O C18H27NO2 289.204179
LMFA08020190 N,N-diethyl-3-hydroxybut-2-enamide N,N-diethyl-3-hydroxybut-2-enamide NA 8:1;O C8H15NO2 157.110279
LMFA08020191 N-Cyclopropyl-trans-2-cis-6-nonadienamide (2E,6Z)-N-cyclopropylnona-2,6-dienamide NA 12:3 C12H19NO 193.146664
LMFA08020192 Neopellitorine A (2E,4E)-N-(2-methylpropyl)undeca-2,4-dien-7,9-diynamide NA 15:6 C15H19NO 229.146664
LMFA08020193 N-Ethyl trans-2-cis-6-nonadienamide (2E,6Z)-N-ethylnona-2,6-dienamide NA 11:2 C11H19NO 181.146664
LMFA08020194 N-formylmaleamic acid (2Z)-4-formamido-4-oxobut-2-enoic acid NA 5:3;O3 C5H5NO4 143.021859
LMFA08020195 N-Isobutyl-2,4,8,10,12-tetradecapentaenamide (2E,4E,8E,10E,12E)-N-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide NA 18:5 C18H27NO 273.209264
LMFA08020199 phenyl [1-(N-succinylamino)pentyl]phosphonate 4-({(1R)-1-[(R)-hydroxy(phenoxy)phosphoryl]pentyl}amino)-4-oxobutanoic acid C15H22NO6P 343.118475
LMFA08020200 Pipericine (2E,4E)-N-(2-methylpropyl)octadeca-2,4-dienamide NA 22:2 C22H41NO 335.318814
LMFA08020204 TMC-1A (2E)-N-[(3S,4R)-3,4-dihydroxy-3-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-6-oxocyclohex-1-en-1-yl]-2,4-dimethyloct-2-enamide C28H36N2O7 512.252253
LMFA08020205 TMC-1C (2E,4E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohex-1-en-1-yl]-4,6-dimethyldeca-2,4-dienamide C30H38N2O7 538.267903
LMFA08020206 TMC-1D (2E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopenten-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohexen-1-yl]-4,6-dimethyldec-2-enamide C30H40N2O7 540.283553
LMFA07070010 (11Z)-eicoseneoylcarnitine 3-[(11Z)-icos-11-enoyloxy]-4-(trimethylazaniumyl)butanoate CAR 20:1 C27H51NO4 453.381810
LMFA07070011 (11Z,14Z)-eicosadienoylcarnitine 3-[(11Z,14Z)-icosa-11,14-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 20:2 C27H49NO4 451.366160
LMFA07070012 (13Z,16Z)-docosadienoylcarnitine 3-[(13Z,16Z)-docosa-13,16-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 22:2 C29H53NO4 479.397460
LMFA07070013 (2E)-hexenedioylcarnitine 3-{[(2E)-5-carboxypent-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 6:2;O2 C13H21NO6 287.136889
LMFA07070014 (2E)-octenoylcarnitine 3-[(2E)-oct-2-enoyloxy]-4-(trimethylazaniumyl)butanoate CAR 8:1 C15H27NO4 285.194009
LMFA07070015 (2E,4Z)-decadienoylcarnitine 3-[(2E,4Z)-deca-2,4-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 10:2 C17H29NO4 311.209659
LMFA07070016 (2E,5Z,7E)-decatrienoylcarnitine 3-[(2E,5Z,7E)-deca-2,5,7-trienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 10:3 C17H27NO4 309.194009
LMFA07070017 (4Z)-decenoylcarnitine 3-[(4Z)-dec-4-enoyloxy]-4-(trimethylazaniumyl)butanoate CAR 10:1 C17H31NO4 313.225309
LMFA07070018 (5Z)-13-carboxytridec-5-enoylcarnitine 3-{[(5Z)-13-carboxytridec-5-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 14:2;O2 C21H37NO6 399.262089
LMFA07070019 (5Z,8Z)-3-hydroxytetradecadienoylcarnitine 3-{[(5Z,8Z)-3-hydroxytetradeca-5,8-dienoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 14:2;O C21H37NO5 383.267174
LMFA07070020 (5Z,8Z)-tetradecadienoylcarnitine 3-[(5Z,8Z)-tetradeca-5,8-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 14:2 C21H37NO4 367.272259
LMFA07070021 (7Z,10Z)-hexadecadienoylcarnitine 3-[(7Z,10Z)-hexadeca-7,10-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 16:2 C23H41NO4 395.303559
LMFA07070022 (7Z,10Z,13Z,16Z)-docosatetraenoylcarnitine 3-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyloxy]-4-(trimethylazaniumyl)butanoate CAR 22:4 C29H49NO4 475.366160
LMFA07070023 (7Z,10Z,13Z,16Z,19Z)-docosapentaenoylcarnitine 3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyloxy]-4-(trimethylazaniumyl)butanoate CAR 22:5 C29H47NO4 473.350510
LMFA07070024 (9Z)-3-hydroxydodecenoylcarnitine 3-{[(9Z)-3-hydroxydodec-9-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 12:1;O C19H35NO5 357.251524
LMFA07070025 (9Z)-3-hydroxyoctadecenoylcarnitine 3-{[(9Z)-3-hydroxyoctadec-9-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 18:1;O C25H47NO5 441.345425